Francesco et al. reported that DNMT1 expression was increased in late-onset AD patients, along with DNA methylation elevation which is positively correlated with the AD risk gene APOE ε4, proposing that global DNA methylation could serve as a reliable marker for AD [61]. Here, APOE is linked to Alzheimer disease.